Drug Shortage Report for AVALIDE

Last updated on 2019-02-27 History
Report ID 70230
Drug Identification Number 02241818
Brand name AVALIDE
Common or Proper name Avalide150/12.5
Company Name SANOFI-AVENTIS CANADA INC
Active Ingredient(s) HYDROCHLOROTHIAZIDE IRBESARTAN
Strength(s) 12.5MG 150MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 90
ATC code C09DA
ATC description ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2018-12-12
Estimated end date 2019-02-28
Actual end date 2019-02-26
Shortage status Resolved
Updated date 2019-02-27
Company comments The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. Patients should validate the availability of the product with their respective pharmacy.
Health Canada comments
Company contact information email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2019-02-27 English Compare
v6 2019-02-26 French Compare
v5 2019-02-26 English Compare
v4 2019-01-30 French Compare
v3 2019-01-30 English Compare
v2 2018-12-20 French Compare
v1 2018-12-20 English Compare